Ansgar Beuse, Carsten Grohmann, Hauke M Schadwinkel, Christos Skevas, Martin S Spitzer
{"title":"糖尿病视网膜病变的人工智能检测。","authors":"Ansgar Beuse, Carsten Grohmann, Hauke M Schadwinkel, Christos Skevas, Martin S Spitzer","doi":"10.1055/a-2545-1192","DOIUrl":null,"url":null,"abstract":"<p><p>Screening and timely treatment can avoid the majority of severe vision loss and blindness from diabetic retinopathy. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might reduce the challenges of systematic screening. The German National Care Guideline recommends that individuals with diabetes receive annual or biennial eye examinations to detect treatable DR. Efficient and comprehensive screening of the growing diabetic population requires more and more resources. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might help in coping with the immense screening burden. Many of these AI algorithms have achieved good sensitivity and specificity for detecting treatable DR, as compared to human graders; however, many important challenges remain, such as acceptance, cost-effectiveness, liability issues, IT security, and reimbursement. AI-supported DR screening has so far only been used to a limited extent, even in countries with a developed digital infrastructure. These questions must be addressed before AI-based DR screening can be implemented on a large scale into clinical practice. This overview presents key concepts in development and currently approved AI applications for DR screening.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Artificial Intelligence for the Detection of Diabetic Retinopathy.\",\"authors\":\"Ansgar Beuse, Carsten Grohmann, Hauke M Schadwinkel, Christos Skevas, Martin S Spitzer\",\"doi\":\"10.1055/a-2545-1192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Screening and timely treatment can avoid the majority of severe vision loss and blindness from diabetic retinopathy. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might reduce the challenges of systematic screening. The German National Care Guideline recommends that individuals with diabetes receive annual or biennial eye examinations to detect treatable DR. Efficient and comprehensive screening of the growing diabetic population requires more and more resources. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might help in coping with the immense screening burden. Many of these AI algorithms have achieved good sensitivity and specificity for detecting treatable DR, as compared to human graders; however, many important challenges remain, such as acceptance, cost-effectiveness, liability issues, IT security, and reimbursement. AI-supported DR screening has so far only been used to a limited extent, even in countries with a developed digital infrastructure. These questions must be addressed before AI-based DR screening can be implemented on a large scale into clinical practice. This overview presents key concepts in development and currently approved AI applications for DR screening.</p>\",\"PeriodicalId\":17904,\"journal\":{\"name\":\"Klinische Monatsblatter fur Augenheilkunde\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinische Monatsblatter fur Augenheilkunde\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2545-1192\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Monatsblatter fur Augenheilkunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2545-1192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Artificial Intelligence for the Detection of Diabetic Retinopathy.
Screening and timely treatment can avoid the majority of severe vision loss and blindness from diabetic retinopathy. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might reduce the challenges of systematic screening. The German National Care Guideline recommends that individuals with diabetes receive annual or biennial eye examinations to detect treatable DR. Efficient and comprehensive screening of the growing diabetic population requires more and more resources. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might help in coping with the immense screening burden. Many of these AI algorithms have achieved good sensitivity and specificity for detecting treatable DR, as compared to human graders; however, many important challenges remain, such as acceptance, cost-effectiveness, liability issues, IT security, and reimbursement. AI-supported DR screening has so far only been used to a limited extent, even in countries with a developed digital infrastructure. These questions must be addressed before AI-based DR screening can be implemented on a large scale into clinical practice. This overview presents key concepts in development and currently approved AI applications for DR screening.
期刊介绍:
-Konzentriertes Fachwissen aus Klinik und Praxis:
Die entscheidenden Ergebnisse der internationalen Forschung - für Sie auf den Punkt gebracht und kritisch kommentiert,
Übersichtsarbeiten zu den maßgeblichen Themen der täglichen Praxis,
Top informiert - breite klinische Berichterstattung.
-CME-Punkte sammeln mit dem Refresher:
Effiziente, CME-zertifizierte Fortbildung, mit dem Refresher,
3 CME-Punkte pro Ausgabe - bis zu 36 CME-Punkte im Jahr!.
-Aktuelle Rubriken mit echtem Nutzwert:
Kurzreferate zu den wichtigsten Artikeln internationaler Zeitschriften,
Schwerpunktthema in jedem Heft: Ausführliche Übersichtsarbeiten zu den wichtigsten Themen der Ophthalmologie – so behalten Sie das gesamte Fach im Blick!,
Originalien mit den neuesten Entwicklungen,
Übersichten zu den relevanten Themen.